HAL (France)open access
Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates
CD40, 2, 0, Non-human primate, Immunogenicity, 1, Preclinical study, Dendritic cell targeting vaccine
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 408778
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.